Valeur202020212022202320242025TTMFrais de vente, généraux et administratifs8.85 B10.54 B7.78 B8.66 B8.51 B8.1 B8.1 BRecherche et développement———————Résultat d'exploitation-5.04 B2.04 B4.38 B3.91 B4.42 B6.21 B6.21 BTotal des produits hors exploitation223 M259 M497 M132 M202 M236 M236 MCharges d'intérêts, nettes des intérêts capitalisés217 M178 M248 M252 M265 M247 M247 MRésultat hors exploitation, hors charges d'intérêts-24 M-22 M-30 M-154 M240 M-55 M260 MRevenus/dépenses exceptionnels30 M103 M279 M34 M-38 M44 M—Résultat avant impôts-5.03 B1.93 B4.63 B3.79 B4.36 B6.2 B6.2 BPart des actionnaires dans le résultat48 M43 M5 M4 M9 M7 M—Impôts-695 M636 M905 M629 M878 M1.1 B1.1 BIntérêts ne donnant pas le contrôle / intérêts minoritaires199 M173 M162 M158 M186 M337 M337 MAutres produits/charges après impôts-188 M-501 M-298 M-233 M-424 M-302 M-302 MRésultat net avant activités abandonnées-4.54 B1.12 B3.56 B3 B3.29 B4.76 B4.76 BActivités abandonnées-1 M-5 M-3 M00——Résultat net-4.54 B1.11 B3.56 B3 B3.29 B4.76 B4.76 BAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires-4.54 B1.11 B3.56 B3 B3.29 B4.76 B4.76 BBénéfice par action de base (BPA de base)-28.267.3225.2322.5425.8638.5538.55Bénéfice par action dilué (BPA dilué)-28.267.2325.0322.3925.7238.3838.38Nombre moyen d'actions de base en circulation160.6 M152.3 M141.1 M133.2 M127.4 M123.6 M—Nombre d'actions en circulation après dilution160.6 M154.1 M142.2 M134.1 M128.1 M124.1 M—EBITDA-4.7 B2.35 B4.65 B4.19 B4.69 B6.5 B6.94 BEBIT-5.04 B2.04 B4.38 B3.91 B4.42 B6.21 B6.21 BCoût des ventes226.08 B250.84 B264.35 B296.12 B345.73 B388.88 B388.88 BAutres coûts des ventes———————Amortissements (flux de trésorerie)344 M312 M272 M279 M272 M287 M729 M
McKesson Corporation Common Stock
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.